David A. Geller

35.7k total citations · 6 hit papers
387 papers, 23.3k citations indexed

About

David A. Geller is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, David A. Geller has authored 387 papers receiving a total of 23.3k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Surgery, 139 papers in Hepatology and 117 papers in Oncology. Recurrent topics in David A. Geller's work include Hepatocellular Carcinoma Treatment and Prognosis (96 papers), Organ Transplantation Techniques and Outcomes (68 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (56 papers). David A. Geller is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (96 papers), Organ Transplantation Techniques and Outcomes (68 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (56 papers). David A. Geller collaborates with scholars based in United States, China and Japan. David A. Geller's co-authors include Timothy R. Billiar, Allan Tsung, T. Clark Gamblin, Andreas K. Nüssler, Kevin T. Nguyen, Richard A. Shapiro, J. Wallis Marsh, Mauricio Di Silvio, Qiang Du and Richard L. Simmons and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David A. Geller

381 papers receiving 22.9k citations

Hit Papers

The nuclear factor HMGB1 mediates hepatic injury after ... 1993 2026 2004 2015 2005 2009 1993 1993 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Geller United States 78 7.0k 7.0k 5.2k 5.1k 4.3k 387 23.3k
Dieter Häussinger Germany 90 7.0k 1.0× 14.9k 2.1× 10.3k 2.0× 6.1k 1.2× 3.0k 0.7× 829 40.2k
Allan Tsung United States 70 4.5k 0.6× 3.4k 0.5× 4.2k 0.8× 4.4k 0.9× 5.5k 1.3× 342 18.1k
Tania Roskams Belgium 83 8.3k 1.2× 11.6k 1.7× 6.6k 1.3× 4.7k 0.9× 1.7k 0.4× 428 25.9k
Toshio Ogihara Japan 89 6.3k 0.9× 1.7k 0.2× 10.2k 2.0× 1.7k 0.3× 2.4k 0.6× 893 31.9k
Nicholas F. LaRusso United States 97 12.2k 1.7× 10.8k 1.5× 7.0k 1.3× 5.2k 1.0× 1.4k 0.3× 404 28.1k
Jack R. Wands United States 86 2.3k 0.3× 7.5k 1.1× 10.6k 2.0× 2.7k 0.5× 2.2k 0.5× 445 29.0k
Simon C. Robson United States 85 6.4k 0.9× 1.5k 0.2× 6.6k 1.3× 3.0k 0.6× 7.0k 1.6× 473 27.7k
Vijay H. Shah United States 78 3.1k 0.4× 7.0k 1.0× 5.6k 1.1× 1.3k 0.3× 1.4k 0.3× 326 18.9k
Norio Hayashi Japan 81 2.1k 0.3× 7.9k 1.1× 11.6k 2.2× 2.3k 0.5× 4.8k 1.1× 623 26.4k
Tooru Shimosegawa Japan 80 13.2k 1.9× 2.2k 0.3× 5.3k 1.0× 7.0k 1.4× 3.2k 0.7× 702 25.7k

Countries citing papers authored by David A. Geller

Since Specialization
Citations

This map shows the geographic impact of David A. Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Geller more than expected).

Fields of papers citing papers by David A. Geller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Geller. The network helps show where David A. Geller may publish in the future.

Co-authorship network of co-authors of David A. Geller

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Geller. A scholar is included among the top collaborators of David A. Geller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Geller. David A. Geller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bou‐Samra, Patrick, et al.. (2025). Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90. Journal of the Egyptian National Cancer Institute. 37(1). 11–11.
2.
Yu, Yanping, Silvia Liu, David A. Geller, & Jianhua Luo. (2024). Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine Learning. American Journal Of Pathology. 194(7). 1262–1271. 6 indexed citations
3.
Bernier, Angelina, Tania S. Burgert, David A. Geller, et al.. (2024). Distinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary Syndrome. Journal of the Endocrine Society. 8(2). bvad169–bvad169. 7 indexed citations
4.
Cui, Xiao, Sheng Wei, Qiang Du, et al.. (2023). Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages. Neoplasia. 40. 100900–100900. 18 indexed citations
5.
Geller, David A., Samer Tohme, Michael H. Antoni, et al.. (2023). Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic Cancers. Current Oncology. 30(10). 8826–8840. 4 indexed citations
6.
Du, Qiang, et al.. (2022). Downregulation of iNOS/NO Promotes Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer. Molecular Cancer Research. 21(2). 102–114. 12 indexed citations
7.
Dogeas, Epameinondas, David A. Geller, Samer Tohme, et al.. (2022). Textbook Outcomes After Open Live Donor Right Hepatectomy and Open Right Hepatic Lobectomy for Cancer in 686 patients. Annals of Surgery. 278(2). e256–e263. 7 indexed citations
8.
Steel, Jennifer L., Michael H. Antoni, Marci L. Nilsen, et al.. (2022). The benefits and consequences of the COVID‐19 pandemic for patients diagnosed with cancer and their family caregivers. Psycho-Oncology. 31(6). 1003–1012. 8 indexed citations
9.
Ziogas, Ioannis A., Stepan M. Esagian, Dimitrios Giannis, et al.. (2021). Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma: An individual patient data survival meta-analysis. The American Journal of Surgery. 222(4). 731–738. 14 indexed citations
10.
Chen, Qi, Lauren Terhorst, David A. Geller, et al.. (2020). Trajectories and predictors of stress and depressive symptoms in spousal and intimate partner cancer caregivers. Journal of Psychosocial Oncology. 38(5). 527–542. 7 indexed citations
11.
Yazdani, Hamza O., Dirk J. van der Windt, Hongji Zhang, et al.. (2019). Neutrophil Extracellular Traps Drive Mitochondrial Homeostasis in Tumors to Augment Growth. Cancer Research. 79(21). 5626–5639. 213 indexed citations
12.
Steel, Jennifer L., Hannah Cheng, Yisi Wang, et al.. (2019). Psychosocial and behavioral pathways of metabolic syndrome in cancer caregivers. Psycho-Oncology. 28(8). 1735–1742. 16 indexed citations
13.
Cheng, Hannah, Thomas W. Kamarck, Peter J. Gianaros, et al.. (2019). Socioeconomic disparities of depressive symptoms and cytokines in hepatocellular carcinoma. Psycho-Oncology. 28(8). 1624–1632. 7 indexed citations
14.
Geller, David A., Allan Tsung, Yisi Wang, et al.. (2019). Illness perceptions and perceived stress in patients with advanced gastrointestinal cancer. Psycho-Oncology. 28(7). 1513–1519. 43 indexed citations
15.
Vujanović, Lazar, Elizabeth C. Stahl, Angela D. Pardee, et al.. (2017). Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer–Cell Activation and Subsequent Cell Death. Cancer Immunology Research. 5(6). 493–502. 27 indexed citations
16.
Ono, Yoshihiro, Toshimasa Nakao, Helong Dai, et al.. (2017). Graft‐infiltrating PD‐L1hi cross‐dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance. Hepatology. 67(4). 1499–1515. 83 indexed citations
17.
Du, Qiang, et al.. (2013). Nitric Oxide Production Upregulates Wnt/β-Catenin Signaling by Inhibiting Dickkopf-1. Cancer Research. 73(21). 6526–6537. 51 indexed citations
18.
Du, Qiang, Xinglu Zhang, Jon Cardinal, et al.. (2009). Wnt/β-Catenin Signaling Regulates Cytokine-Induced Human Inducible Nitric Oxide Synthase Expression by Inhibiting Nuclear Factor-κB Activation in Cancer Cells. Cancer Research. 69(9). 3764–3771. 98 indexed citations
19.
Du, Qiang, Kyong Soo Park, Zhong Guo, et al.. (2006). Regulation of Human Nitric Oxide Synthase 2 Expression by Wnt β-Catenin Signaling. Cancer Research. 66(14). 7024–7031. 88 indexed citations
20.
Tsoulfas, George & David A. Geller. (2001). NF-κB in transplantation: friend or foe?. Transplant Infectious Disease. 3(4). 212–219. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026